NRX Pharmaceuticals Price To Book vs. Total Debt
| NRXP Stock | USD 2.27 0.02 0.87% |
For NRX Pharmaceuticals profitability analysis, we use financial ratios and fundamental drivers that measure the ability of NRX Pharmaceuticals to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well NRX Pharmaceuticals utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between NRX Pharmaceuticals's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of NRX Pharmaceuticals over time as well as its relative position and ranking within its peers.
NRX |
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of NRX Pharmaceuticals. If investors know NRX will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about NRX Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of NRX Pharmaceuticals is measured differently than its book value, which is the value of NRX that is recorded on the company's balance sheet. Investors also form their own opinion of NRX Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is NRX Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because NRX Pharmaceuticals' market value can be influenced by many factors that don't directly affect NRX Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between NRX Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if NRX Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, NRX Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
NRX Pharmaceuticals Total Debt vs. Price To Book Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining NRX Pharmaceuticals's current stock value. Our valuation model uses many indicators to compare NRX Pharmaceuticals value to that of its competitors to determine the firm's financial worth. NRX Pharmaceuticals is regarded third in price to book category among its peers. It is regarded fourth in total debt category among its peers making up about 3,154,397 of Total Debt per Price To Book. As of 03/02/2025, Total Debt To Capitalization is likely to grow to -3.89. Comparative valuation analysis is a catch-all technique that is used if you cannot value NRX Pharmaceuticals by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.NRX Total Debt vs. Price To Book
Price to Book (P/B) ratio is used to relate a company book value to its current market price. A high P/B ratio indicates that investors expect executives to generate more returns on their investments from a given set of assets. Book value is the accounting value of assets minus liabilities.
NRX Pharmaceuticals |
| = | 2.90 X |
Price to Book ratio is mostly used in financial services industries where assets and liabilities are typically represented by dollars. Although low Price to Book ratio generally implies that the firm is undervalued, it is often a good indicator that the company may be in financial or managerial distress and should be investigated more carefully.
Total Debt refers to the amount of long term interest-bearing liabilities that a company carries on its balance sheet. That may include bonds sold to the public, notes written to banks or capital leases. Typically, debt can help a company magnify its earnings, but the burden of interest and principal payments will eventually prevent the firm from borrow excessively.
NRX Pharmaceuticals |
| = | 9.16 M |
In most industries, total debt may also include the current portion of long-term debt. Since debt terms vary widely from one company to another, simply comparing outstanding debt obligations between different companies may not be adequate. It is usually meant to compare total debt amounts between companies that operate within the same sector.
NRX Total Debt vs Competition
NRX Pharmaceuticals is regarded fourth in total debt category among its peers. Total debt of Health Care industry is now estimated at about 96.53 Million. NRX Pharmaceuticals holds roughly 9.16 Million in total debt claiming about 9% of equities under Health Care industry.
NRX Pharmaceuticals Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in NRX Pharmaceuticals, profitability is also one of the essential criteria for including it into their portfolios because, without profit, NRX Pharmaceuticals will eventually generate negative long term returns. The profitability progress is the general direction of NRX Pharmaceuticals' change in net profit over the period of time. It can combine multiple indicators of NRX Pharmaceuticals, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Accumulated Other Comprehensive Income | -3.5 K | -3.6 K | |
| Interest Income | 495 K | 372.8 K | |
| Operating Income | -24.8 M | -26.1 M | |
| Income Before Tax | -27.1 M | -28.5 M | |
| Net Loss | -35.8 M | -37.6 M | |
| Net Loss | -27.1 M | -28.5 M | |
| Total Other Income Expense Net | -3 M | -3.1 M | |
| Income Tax Expense | -10.3 K | -10.9 K | |
| Net Interest Income | 590 K | 619.4 K | |
| Net Loss | -32.5 M | -34.1 M | |
| Non Operating Income Net Other | -272.7 K | -286.4 K | |
| Change To Netincome | 69.3 M | 39.4 M | |
| Net Loss | (4.58) | (4.35) | |
| Income Quality | 0.65 | 0.68 | |
| Net Income Per E B T | 0.90 | 0.60 |
NRX Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on NRX Pharmaceuticals. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of NRX Pharmaceuticals position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the NRX Pharmaceuticals' important profitability drivers and their relationship over time.
Learn to be your own money manager
Our tools can tell you how much better you can do entering a position in NRX Pharmaceuticals without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Financial Widgets Now
Financial WidgetsEasily integrated Macroaxis content with over 30 different plug-and-play financial widgets |
| All Next | Launch Module |
Use Investing Themes to Complement your NRX Pharmaceuticals position
In addition to having NRX Pharmaceuticals in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Raw Materials Thematic Idea Now
Raw Materials
Companies that are involved with the development and processing of raw materials such as silver or forestry. The Raw Materials theme has 15 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Raw Materials Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for NRX Stock Analysis
When running NRX Pharmaceuticals' price analysis, check to measure NRX Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NRX Pharmaceuticals is operating at the current time. Most of NRX Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of NRX Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NRX Pharmaceuticals' price. Additionally, you may evaluate how the addition of NRX Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.